Adaptive Stock Volatility

ADPT Stock  USD 7.05  0.09  1.29%   
Adaptive Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.0508, which signifies that the company had -0.0508% of return per unit of standard deviation over the last 3 months. Our philosophy in foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Adaptive Biotechnologies Corp exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its stock price that cannot be diversified away. Please confirm Adaptive Biotechnologies mean deviation of 3.32, and Risk Adjusted Performance of (0.035207) to double-check the risk estimate we provide.
Adaptive Biotechnologies Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Adaptive daily returns, and it is calculated using variance and standard deviation. We also use Adaptive's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Adaptive Biotechnologies volatility.

30 Days Market Risk

Slightly risky

Chance of Distress

30 Days Economic Sensitivity

Actively responds to the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Adaptive Biotechnologies can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Adaptive Biotechnologies at lower prices. For example, an investor can purchase Adaptive stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Adaptive Biotechnologies' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Adaptive Stock

+0.72AAgilent Technologies Fiscal Quarter End 31st of July 2023 PairCorr
+0.64EQEquillium Fiscal Quarter End 30th of June 2023 PairCorr
+0.87DMTKDermTech Fiscal Quarter End 30th of June 2023 PairCorr
+0.63VBIVVBI Vaccines Fiscal Quarter End 30th of June 2023 PairCorr

Moving against Adaptive Stock

-0.78VCELVericel Corp Ord Fiscal Quarter End 30th of June 2023 PairCorr
-0.72DICEDice Molecules Holdings Fiscal Quarter End 30th of June 2023 PairCorr
-0.72VKTXViking Therapeutics Fiscal Quarter End 30th of June 2023 PairCorr
-0.7DNLIDenali Therapeutics Fiscal Quarter End 30th of June 2023 PairCorr
-0.63DYAIDyadic International Fiscal Quarter End 30th of June 2023 PairCorr
-0.62DVAXDynavax Technologies Fiscal Quarter End 30th of June 2023 PairCorr
-0.6VBLTVascular Biogenics Fiscal Quarter End 30th of June 2023 PairCorr
-0.53DRRXDurect Fiscal Quarter End 30th of June 2023 PairCorr
-0.48VCYTVeracyte Fiscal Quarter End 30th of June 2023 PairCorr

Adaptive Biotechnologies Market Sensitivity And Downside Risk

Adaptive Biotechnologies' beta coefficient measures the volatility of Adaptive stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Adaptive stock's returns against your selected market. In other words, Adaptive Biotechnologies's beta of 1.61 provides an investor with an approximation of how much risk Adaptive Biotechnologies stock can potentially add to one of your existing portfolios.
Adaptive Biotechnologies Corp exhibits very low volatility with skewness of -0.65 and kurtosis of 0.78. However, we advise investors to further study Adaptive Biotechnologies Corp technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Adaptive Biotechnologies' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Adaptive Biotechnologies' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
3 Months Beta |Analyze Adaptive Biotechnologies Demand Trend
Check current 90 days Adaptive Biotechnologies correlation with market (NYSE Composite)

Adaptive Beta

Adaptive standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

It is essential to understand the difference between upside risk (as represented by Adaptive Biotechnologies's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Adaptive Biotechnologies' daily returns or price. Since the actual investment returns on holding a position in adaptive stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Adaptive Biotechnologies.

Using Adaptive Put Option to Manage Risk

Put options written on Adaptive Biotechnologies grant holders of the option the right to sell a specified amount of Adaptive Biotechnologies at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Adaptive Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Adaptive Biotechnologies' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Adaptive Biotechnologies will be realized, the loss incurred will be offset by the profits made with the option trade.

Adaptive Biotechnologies' PUT expiring on 2023-06-16

       Adaptive Biotechnologies Price At Expiration  

Current Adaptive Biotechnologies Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
2023-06-16 PUT at $10.0-0.96620.057612023-06-162.8 - 3.32.45View
2023-06-16 PUT at $7.5-0.63450.31721892023-06-160.5 - 0.90.8View
View All Adaptive Biotechnologies Options

Adaptive Biotechnologies Stock Volatility Analysis

Volatility refers to the frequency at which Adaptive Biotechnologies stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Adaptive Biotechnologies' price changes. Investors will then calculate the volatility of Adaptive Biotechnologies' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Adaptive Biotechnologies' volatility:

Historical Volatility

This type of stock volatility measures Adaptive Biotechnologies' fluctuations based on previous trends. It's commonly used to predict Adaptive Biotechnologies' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Adaptive Biotechnologies' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Adaptive Biotechnologies' to be redeemed at a future date.
The output start index for this execution was zero with a total number of output elements of sixty-one. Adaptive Biotechnologies Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Adaptive Biotechnologies Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 1.6127 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Adaptive Biotechnologies will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Adaptive Biotechnologies or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Adaptive Biotechnologies' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Adaptive stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Adaptive Biotechnologies is significantly underperforming NYSE Composite.
   Predicted Return Density   
Adaptive Biotechnologies' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how adaptive stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Adaptive Biotechnologies Price Volatility?

Several factors can influence a stock's market volatility:


Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Adaptive Biotechnologies Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Adaptive Biotechnologies or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Adaptive Biotechnologies' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Adaptive stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Given the investment horizon of 90 days the coefficient of variation of Adaptive Biotechnologies is -1967.55. The daily returns are distributed with a variance of 16.85 and standard deviation of 4.1. The mean deviation of Adaptive Biotechnologies Corp is currently at 3.16. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.9
Alpha over NYSE Composite
Beta against NYSE Composite1.61
Overall volatility
Information ratio -0.04

Adaptive Biotechnologies Stock Return Volatility

Adaptive Biotechnologies historical daily return volatility represents how much of Adaptive Biotechnologies stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 4.1047% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.9143% volatility on return distribution over the 90 days horizon.
 Performance (%) 

About Adaptive Biotechnologies Volatility

Volatility is a rate at which the price of Adaptive Biotechnologies or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Adaptive Biotechnologies may increase or decrease. In other words, similar to Adaptive's beta indicator, it measures the risk of Adaptive Biotechnologies and helps estimate the fluctuations that may happen in a short period of time. So if prices of Adaptive Biotechnologies fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for 2023
Market Capitalization1.1 B1.1 B
Adaptive Biotechnologies' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Adaptive Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Adaptive Biotechnologies' price varies over time.

3 ways to utilize Adaptive Biotechnologies' volatility to invest better

Higher Adaptive Biotechnologies' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Adaptive Biotechnologies stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Adaptive Biotechnologies stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Adaptive Biotechnologies investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Adaptive Biotechnologies' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Adaptive Biotechnologies' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Adaptive Biotechnologies Investment Opportunity

Adaptive Biotechnologies Corp has a volatility of 4.1 and is 4.51 times more volatile than NYSE Composite. 35  of all equities and portfolios are less risky than Adaptive Biotechnologies. Compared to the overall equity markets, volatility of historical daily returns of Adaptive Biotechnologies Corp is lower than 35 () of all global equities and portfolios over the last 90 days. Use Adaptive Biotechnologies Corp to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a large bullish trend. Check odds of Adaptive Biotechnologies to be traded at $7.76 in 90 days.

Weak diversification

The correlation between Adaptive Biotechnologies Corp and NYA is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adaptive Biotechnologies Corp and NYA in the same portfolio, assuming nothing else is changed.

Adaptive Biotechnologies Additional Risk Indicators

The analysis of Adaptive Biotechnologies' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Adaptive Biotechnologies' investment and either accepting that risk or mitigating it. Along with some common measures of Adaptive Biotechnologies stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Adaptive Biotechnologies Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Adaptive Biotechnologies as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Adaptive Biotechnologies' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Adaptive Biotechnologies' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Adaptive Biotechnologies Corp.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptive Biotechnologies Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Adaptive Stock analysis

When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
CEO Directory
Screen CEOs from public companies around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Adaptive Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.